Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)-Reference-Cited by-同舟云学术

Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)

Published:2024-03 Issue:9 Volume:31 Page:1165-1169
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

De Surya K.¹²

Affiliation:

1. Department of Chemistry, Conju-Probe, San Diego, California, USA

2. Department of Chemistry, Bharath University, Chennai, Tamil Nadu, 600126, India

Abstract

Abstract: The application describes compounds, such as compounds of general Formula, with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and synthetic methods of various compounds with warheads are included. The compounds are inhibitors of proteases, such as the 3C, CL- or 3CL-like protease.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Reference12 articles.

1. Ábrányi-Balogh P.; Petri L.; Imre T.; Szijj P.; Scarpino A.; Hrast M.; Mitrović A.; Fonovič U.P.; Németh, K.; Barreteau, H.; Roper, D.I.; Horváti, K.; Ferenczy, G.G.; Kos, J.; Ilaš, J.; Gobec, S.; Keserű G.M. A road map for prioritizing warheads for cysteine targeting covalent inhibitors. Eur J Med Chem 2018,160,94-107

2. Yu W.; Zhao Y.; Ye H.; Wu N.; Liao Y.; Chen N.; Li Z.; Wan N.; Hao H.; Yan H.; Xiao Y.; Lai M.; Structure-based design of a dual-targeted covalent inhibitor against papain-like and main proteases of SARS-CoV-2. J Med Chem 2022,65(24),16252-16267

3. Ullrich S.; Nitsche C.; SARS‐CoV‐2 papain‐like protease: Structure, function and inhibition. ChemBioChem 2022,23(19),e202200327

4. Alzyoud L.; Ghattas M.A.; Atatreh N.; Allosteric binding sites of the SARS-CoV-2 main protease: Potential targets for broad-spectrum anti-coronavirus agents. Drug Des Devel Ther 2022,16,2463-2478

5. Cherqaoui D.; Oubahmane M.; Hdoufane I.; Bjij I.; Lahcen N.A.; Villemin D.; Daoud R.; Allali A.E.; Host cell proteases mediating SARS-CoV-2 entry: An overview. Curr Top Med Chem 2022,22(21),1776-1792